- Home
- SGMO vs JLS Comparison
SGMO vs JLS Comparison
Compare SGMO & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- JLS
- Stock Information
- Founded
- SGMO 1995
- JLS 2009
- Country
- SGMO United States
- JLS United States
- Employees
- SGMO N/A
- JLS N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- JLS Investment Managers
- Sector
- SGMO Health Care
- JLS Finance
- Exchange
- SGMO Nasdaq
- JLS Nasdaq
- Market Cap
- SGMO 122.8M
- JLS 103.4M
- IPO Year
- SGMO 2000
- JLS N/A
- Fundamental
- Price
- SGMO $0.58
- JLS $18.78
- Analyst Decision
- SGMO Buy
- JLS
- Analyst Count
- SGMO 6
- JLS 0
- Target Price
- SGMO $4.50
- JLS N/A
- AVG Volume (30 Days)
- SGMO 7.8M
- JLS 26.6K
- Earning Date
- SGMO 08-07-2025
- JLS 01-01-0001
- Dividend Yield
- SGMO N/A
- JLS 9.33%
- EPS Growth
- SGMO N/A
- JLS N/A
- EPS
- SGMO N/A
- JLS N/A
- Revenue
- SGMO $81,706,000.00
- JLS N/A
- Revenue This Year
- SGMO $1.29
- JLS N/A
- Revenue Next Year
- SGMO $1.60
- JLS N/A
- P/E Ratio
- SGMO N/A
- JLS N/A
- Revenue Growth
- SGMO 565.52
- JLS N/A
- 52 Week Low
- SGMO $0.41
- JLS $15.48
- 52 Week High
- SGMO $3.18
- JLS $17.97
- Technical
- Relative Strength Index (RSI)
- SGMO 58.57
- JLS 45.16
- Support Level
- SGMO $0.50
- JLS $18.87
- Resistance Level
- SGMO $0.58
- JLS $19.00
- Average True Range (ATR)
- SGMO 0.05
- JLS 0.12
- MACD
- SGMO 0.00
- JLS -0.02
- Stochastic Oscillator
- SGMO 84.21
- JLS 7.69
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About JLS Nuveen Mortgage and Income Fund
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.